公开(公告)号：US20150105420A1

公开(公告)日：2015-04-16

申请号：US14572218

申请日：2014-12-16

Applicant: LEO Pharma A/S

Inventor： Simon Feldbaek NIELSEN ,  Jens Christian Hojland LARSEN

IPC: C07D471/04 ,  A61K31/437

CPC classification number: C07D471/04 ,  A61K31/437

Abstract: The present invention relates to novel [1,2,4]triazolopyridine compounds with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.

Abstract translation: 本发明涉及具有磷酸二酯酶抑制活性的新型[1,2,4]三唑并吡啶化合物，以及它们在治疗炎性疾病和病症中作为治疗剂的用途。